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IL-27 is a heterodimeric cytokine formed by as-
sociation of the subunit proteins IL-27p28 and 
Epstein Bar virus–induced protein 3 (Ebi3; Pflanz 
et al., 2002). It is predominantly expressed by 
myeloid cells and signals through a heterodimeric 
receptor that consists of IL-27Ra (WSX-1, 
TCCR) and gp130 (Pflanz et al., 2004) and is ex-
pressed throughout the immune system. Most   
of the studies on IL-27 have focused on T cells, 
where receptor ligation results in activation of the 
TH1 transcription factors T-bet and STAT1, as 
well as subsequent up-regulation of the IL-12R2 
chain. Despite this apparent TH1-inducing sig-
naling profile, mice deficient in Ebi3 (Ebi3/) or 
Il27ra (Il27ra/) do not display major defects in 
the ability to mount TH1 responses, even though 
TH1 responses are somewhat delayed in a limited 
number of infectious scenarios (Batten and 
Ghilardi, 2007). Instead, these mice exhibit exac-
erbated inflammation in response to a wide vari-
ety of immune challenges, including pathogens 
that elicit TH1 and TH2 responses and inflam-
matory models of disease that rely on TH2   
and TH17 activity (Batten and Ghilardi, 2007; 
Kastelein et al., 2007). Several possible mecha-
nisms  for  this  immunomodulatory  activity   
have been identified: IL-27 is known to antago-
nize  TH17  development  (Batten  et  al.,  2006;   
Stumhofer et al., 2006), induce IL-10 production 
(Awasthi  et  al.,  2007;  Fitzgerald  et  al.,  2007; 
Stumhofer et al., 2007; Batten et al., 2008), and 
suppress  IL-6–induced  T  cell  proliferation   
(Batten et al., 2006). Nevertheless, IL-27 plays   
a proinflammatory role in some situations. For 
example, Il27ra/ mice are protected from   
proteoglycan-induced arthritis (Cao et al., 2008) 
and deletion of the Il27ra gene in the MRL/lpr 
model of lupus results in lower TH1 cytokine 
production, diminished anti-dsDNA antibodies, 
and enhanced survival (Shimizu et al., 2005).
Colitis occurs when tolerance to microbial 
antigens is broken, resulting in mucosal inflamma-
tion. In a recent genome-wide association study,   
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Interleukin-27 (IL-27) is a cytokine known to have both proinflammatory and immuno-
regulatory functions. The latter appear to dominate in vivo, where IL-27 suppresses TH17 
responses and promotes the differentiation of Tr1 cells expressing interferon- and IL-10 
and lacking forkhead box P3 (Foxp3). Accordingly, IL-27 receptor  (Il27ra)–deficient mice 
suffer from exacerbated immune pathology when infected with various parasites or chal-
lenged with autoantigens. Because the role of IL-27 in human and experimental mouse 
colitis is controversial, we studied the consequences of Il27ra deletion in the mouse T cell 
transfer model of colitis and unexpectedly discovered a proinflammatory role of IL-27. 
Absence of Il27ra on transferred T cells resulted in diminished weight loss and reduced 
colonic inflammation. A greater fraction of transferred T cells assumed a Foxp3+ phenotype 
in the absence of Il27ra, suggesting that IL-27 functions to restrain regulatory T cell (Treg) 
development. Indeed, IL-27 suppressed Foxp3 induction in vitro and in an ovalbumin-
dependent tolerization model in vivo. Furthermore, effector cell proliferation and IFN- 
production were reduced in the absence of Il27ra. Collectively, we describe a proinflamma-
tory role of IL-27 in T cell–dependent intestinal inflammation and provide a rationale for 
targeting this cytokine in pathological situations that result from a breakdown in periph-
eral immune tolerance.
© 2011 Cox et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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almost completely protected against colitis-induced by oxazo-
lone,  which  induces  a  TH2-type  immune  pathology  and 
involves invariant NK-T cells, but not at all protected when 
colitis  was  induced  by  2,4,6-trinitrobenzenesulfonic  acid,  a 
TH1-promoting agent (Nieuwenhuis et al., 2002).
These discrepant results suggest that IL-27 may have dis-
tinct effects on various cell compartments, and may promote 
or ameliorate colitis depending on the specific circumstances. 
In an effort to reduce complexity, we decided to study the 
role of IL-27 in a T cell transfer model (Powrie et al., 1993), 
which allows for the specific assessment of T cell restricted 
Il27ra deficiency. This model is characterized by colitis and 
systemic wasting disease. Because colitis depends on IL-23 
and TH17 cells (Ahern et al., 2008), and because IL-27 acts 
to suppress TH17 development (Batten et al., 2006; Stumhofer 
et al., 2006), we expected exacerbated colitis in recipients of 
Il27ra/ CD45Rbhi cells. In contrast, absence of IL-27Ra on 
transferred T cells resulted in diminished weight loss and re-
duced colonic inflammation.
RESULTS
Il27ra/ CD4+CD45Rbhi T cells fail to induce  
fulminant colitis
To determine whether IL-27 responsiveness of T cells was 
required for the establishment of the colitis phenotype, we 
used the CD4+CD45Rbhi transfer model of colitis (Powrie   
et al., 1993). First, we crossed the Il27ra/ allele (Chen   
et al., 2000) into the balb/c background for 12 generations.   
As previously described in C57BL/6 mice, Il27ra deficiency 
causes  no  overt  abnormalities  in  the  balb/c 
background (unpublished data). However, to 
our surprise, transfer of FACS-purified balb/c 
Il27ra/ CD45Rbhi T cells into CB17-SCID 
recipient  mice  resulted  in  partial  protection 
against weight loss compared with transfer of 
WT CD45Rbhi T cells (Fig. 1, A and B), sug-
gesting that IL-27 plays a proinflammatory role 
in this model. Upon analysis of the colons at 
the end of the study, we found that recipients 
of Il27ra/ CD45Rbhi cells also displayed a re-
duced amount of colonic shortening (Fig. 1 C) 
and had significantly reduced histological scores 
IL-27p28 was found to be associated specifically with human 
early onset inflammatory bowel disease (IBD; Imielinski et al., 
2009). Consistent with a proposed immunoregulatory function 
of IL-27, the risk allele was found to result in lower expression 
of IL-27 by donor-derived lymphoblastoid cell lines. However, 
two other studies found transcripts for IL-27p28 (Schmidt et al., 
2005) and Ebi3 (Omata et al., 2001) to be overexpressed in   
biopsy samples from IBD patients, which would be consistent 
with either a proinflammatory or an ineffective protective role 
of IL-27 in IBD. Thus, the pathophysiological relevance of   
IL-27 in human IBD remains unresolved.
Similar controversy exists in regard to the role of IL-27 in 
mouse models of colitis. Two groups have studied Il27ra/ 
mice in the context of dextran sulfate sodium (DSS)–induced 
colitis, which is an epithelial damage model, and have come to 
diametrically opposed conclusions. Troy et al. (2009) studied a 
high-dose, acute inflammation model (5–10% DSS in drinking 
water) and found that Il27ra/ mice are more susceptible, 
whereas Honda et al. (2005) used much lower concentrations 
of DSS (0.5% DSS in drinking water) and found Il27ra/ 
mice to be protected. Interestingly, the former study identified 
both adaptive and innate immune cells as targets for IL-27, be-
cause the difference in DSS-induced disease severity persisted 
when the Il27ra/ allele was crossed onto a Rag-deficient 
background (Troy et al., 2009). Another group studied the 
role of IL-27 in a model of helminth-induced IBD and found 
that Il27ra deficiency impairs the intestinal TH1 response, re-
sulting both in ineffective worm expulsion and delayed onset 
of colitis (Villarino et al., 2008). Finally, Ebi3/ mice were   
Figure 1.  Decreased severity of CD45Rbhi colitis in 
the absence of T cell–derived IL-27R. (A) Relative 
weight loss after transfer of CD4+CD45Rbhi or unsorted 
CD4+ cells from WT or Il27ra/ (KO) mice into CB17-
SCID recipients. (B) Weight loss relative to initial weight 
at 11 wk after transfer of CD4+CD45Rbhi or unsorted 
CD4+ cells from WT or KO mice. (C) Colon length mea-
surements at 11 wk after transfer. (D) Histological scoring 
of colitis severity (E) Representative hematoxylin and 
eosin staining of colons from mice transferred with WT 
CD45Rbhi, Il27ra/ CD45Rbhi, or Il27ra/ unsorted 
CD4+ cells. Data are from two experiments representing 
four individual experiments. Bars, 100 µm. *, P < 0.05.JEM VOL. 208, January 17, 2011 
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To enable experiments that are not encumbered by nTreg 
contamination, we bred the Il27ra/ allele into a DO11.10+ 
and Rag2/ background. Such mice contain a pristine pop-
ulation of naive, OVA-specific T cells that is completely de-
void of nTregs (Fig. 3 A), and hence represent an ideal system 
to study Treg conversion. To validate this system, we first cul-
tured DO11.10+Rag2/ T cells in the presence of lamina 
propria DCs (LPDCs), OVA peptide, and TGF-. Indeed, 
lamina  propria  DCs  allowed  for  Foxp3+  conversion,  and   
IL-27 suppressed Treg conversion (Fig. 3 B). However, in this 
experimental  system  IL-27  also  affected  CD25  expression 
(Fig. 1, D and E). Therefore, the presence of Il27ra on T cells 
is required in this model for the development of both fulmi-
nant colitis and maximal weight loss.
Il-27Ra signaling limits conversion of naive T cells  
into Foxp3+ regulatory T cells (Tregs)
As  expected,  control  animals  transferred  with  total  CD4+ 
cells from either genotype suffered from neither weight loss 
nor colitis, and this is because of the presence of natural Tregs 
(nTregs) in the cell graft (Fig. 1). We therefore investigated 
whether a difference in the presence of forkhead box P3–
positive (Foxp3+) cells might account for the observed phe-
notype. As shown in Fig. 2 A, we could detect elevated Treg 
cells in the absence of Il27ra on peripheral blood T cells as 
early as 5 wk after transfer of CD45Rbhi cells. Furthermore, 
when we sacrificed mice at the end of the study, we found 
that recipients of Il27ra/ CD45Rbhi cells contained approxi-
mately two to three times the normal proportion of Foxp3+ 
T cells in blood, spleen, mesenteric LN (mLN), and lamina 
propria (Fig. 2, A–C). In agreement with enhanced suppres-
sive activity, we also noted that Il27ra/ recipients contained 
fewer total CD4+ T cells, especially in the lamina propria 
(Fig. 2, D and E).
Previous studies and experiments done here revealed no 
reduction in the frequency of Foxp3+ cells in naive Il27ra/ 
mice (Fig. S1 A; Batten et al., 2006). Furthermore, the sup-
pressive capacity of these cells in vitro is unaffected by the 
absence of Il27ra (Fig. S2 A; Batten et al., 2006). However, 
because FACS-sorted WT and Il27ra/ CD4+CD45Rbhi 
cells contained 0.5% nTregs (Fig. S2 B), it remained possible 
that  the  increased  frequency  of  Foxp3+  cells  in  Il27ra/ 
CD45Rbhi recipients resulted from preferential in vivo expan-
sion of or enhanced in vivo suppressive capacity by Il27ra/ 
nTregs.  To  address  this  concern,  we  transferred  purified 
CD4+CD25+ cells from WT or Il27ra/ mice into Rag2-
deficient C57BL/6 mice that had been transferred with WT 
CD4+CD45Rbhi cells 7 wk before. nTregs from either geno-
type were fully capable of rescuing their hosts from systemic 
wasting disease (Fig. S2, C and D). Furthermore, we observed 
similar frequencies of Foxp3+ cells of both genotypes in the 
blood, spleen, and mLNs of the rescued recipient animals, 
suggesting that the in vivo expansion rate of nTregs is not   
affected by the Il27ra genotype (Fig. S2, E and F).
IL-27 limits Treg conversion in an OVA-dependent 
tolerization model in vivo
Inducible Tregs develop from naive CD4+ T cells upon stimu-
lation in the presence of TGF-. It has been demonstrated   
in the context of transfer colitis that this type of conversion 
occurs in vivo in a small fraction of the transferred cells (Sun   
et al., 2007); however, the resulting number of Foxp3+ cells 
is insufficient to afford the host full protection, and colitis en-
sues. Prior studies have suggested that IL-27 can suppress the 
TGF-–driven induction of Foxp3+ cells in vitro (Neufert   
et al., 2007; Huber et al., 2008); therefore, we investigated 
whether IL-27 normally restrains Treg conversion in vivo.   
Figure 2.  Il27ra/ CD45Rbhi cells preferentially assume a Foxp3+ 
phenotype. (A) Time course of the percentage of Foxp3+ cells relative to 
CD4+ cells in peripheral blood of mice transferred with CD45Rbhi cells 
from WT or Il27ra/ donor mice. (B) Representative Foxp3 staining of 
splenocytes gated on CD4+ cells at 12 wk after transfer of CD45Rbhi cells. 
(C and D) Frequencies of Foxp3+ CD4+ T cells (C) and total CD4+ cells (D) 
obtained from the spleen, mLN, and lamina propria at 12 wk after transfer. 
(E) Absolute number of CD4+ T cells in spleen, mLN, and lamina propria at 
12 wk after transfer. Data are representative of three individual experi-
ments. *, P < 0.05; ***, P < 0.001.118 IL-27 promotes transfer colitis | Cox et al.
observed that Il27ra deficiency significantly augmented pe-
ripheral Treg development, indicating that IL-27 limits Treg 
conversion even in a noninflammatory environment. This 
effect was further accentuated when we measured absolute 
numbers of Foxp3+ DO11.10+Rag2/ cells (Fig. 4 C). Be-
cause only naive Foxp3 cells were transferred into recipi-
ents,  this  experiment  also  conclusively  proves  that  IL-27 
signaling  limits  Treg  conversion  rather  than  expansion  of 
nTregs. Consistent with previous observations (Villarino et al., 
2006), Il27ra/ DO11.10 cells produced more IL-2 (Fig. 4 D), 
and  generally  suppressed  T  cell  activation  as  measured   
by CD69 surface expression (Fig. 3 C). IL-27 acted directly 
on T cells to down-regulate Foxp3, CD25, and CD69, be-
cause it had no effect when Il27ra/ T cells were used in   
the experiment.
Next, we transferred purified DO11.10+Rag2/ T cells 
into naive balb/c recipients and exposed them to OVA in the 
drinking water. Exposure to antigen led to a significant in-
crease in Foxp3+ cells in the spleens and mLNs (Fig. 4, A–C). 
Consistent with our data obtained from the colitis model, we 
Figure 3.  IL-27 inhibits the induction of 
OVA-specific T regulatory cells in vitro.  
(A) DO11.10+Rag2/ CD4+ T cells were isolated 
from WT or Il27ra/ (KO) mice and confirmed 
to be Foxp3CD25. (B and C) DO11.10+CD4+ 
cells from WT or Il27ra/ mice were incubated 
with CD11c+MHCII+ DCs isolated from the  
colonic lamina propria in the presence of 
OVA323-339 and TGF-, with or without IL-27, 
and stained for Foxp3 and CD25 (B) and CD69 
(C). Ctrl, Control; +27, TGF- + IL-27; ,  
TGF-; Act., Activated. Data are representative 
of two individual experiments.
Figure 4.  Il27ra/ DO11.10+ T cells convert more readily to T regulatory cells in vivo. (A) Representative Foxp3 staining of WT or Il27ra/ (KO) 
DO11.10+ cells after transfer to balb/c mice and oral administration of 1.5% OVA in water for 5 d. (B and C) Quantitative analysis of percentage (B) and 
absolute numbers (C) of Foxp3+ cells in the mLNs and spleens of mice receiving WT or Il27ra/ DO11.10+ T cells and fed 1.5% OVA or control water.  
(D-E) Intracellular cytokine staining analysis of IL-2 (D) and IFN- (E) in the mLNs from OVA-fed or control mice. (F) Absolute numbers of Foxp3+ DO11.10+ 
cells in the mLN of control or OVA-treated mice that had received 3 × 105 CD45Rbhi cells 4 wk earlier. Data are from a single experiment representing two 
individual experiments. *, P < 0.05; ***, P < 0.001.JEM VOL. 208, January 17, 2011 
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Il27ra/ CD45Rbhi cells (Fig. 5, C–E and not depicted). 
However, these changes were effectively neutralized in abso-
lute terms by the lower total number of CD4+ cells (Fig. 2 E 
and not depicted). We did not observe increased neutrophil 
whereas IFN- production was minimal irrespective of Il27ra 
expression in the noninflammatory environment of unchal-
lenged balb/c mice (Fig. 4 E). However, increased production 
of IL-2 is not responsible for enhanced Treg conversion be-
cause IL-2 does not override the suppressive effect of IL-27 
on Foxp3 induction (Neufert et al., 2007 and unpublished 
data), which has been shown in vitro to be a direct, STAT3-
mediated effect of IL-27 on T cells (Huber et al., 2008). Im-
portantly, we still observed enhanced Treg conversion when 
we repeated this experiment under inflammatory conditions 
in mice that had received WT CD45Rbhi cells 4 wk earlier 
(Fig. 4 F), suggesting that the inflammatory milieu by itself is   
insufficient to restrict Foxp3 expression in the absence of IL-27 
signaling. However, introduction of Il27ra/ CD45Rbhi cells 
into mice with preestablished colitis failed to demonstrate a 
therapeutic effect (Fig. S3).
Il27ra/ effector T cells have a different cytokine secretion 
profile compared with their WT counterparts
Despite the increased conversion rate of Il27ra/ CD45Rbhi 
cells, the majority of the transferred cells remained Foxp3. 
We therefore also examined cytokine production in the colon 
by RT-PCR and in restimulated lymphocytes isolated from 
the spleen, the mLN, and the colonic lamina propria of 
CD45Rbhi recipient animals by intracellular staining. Although 
IL-12, IL-23, IL-2, IL-6, and IL-27 were all found to be in-
duced in colitic mice, no statistically significant changes were 
noted between WT and Il27ra/ CD45Rbhi recipients 
(Fig. S4). In accordance with prior observations (Chen et al., 
2000; Artis et al., 2004; Batten et al., 2006; Stumhofer et al., 
2006), T cells isolated from Il27ra/ CD45Rbhi recipients 
produced significantly less IFN- as assessed by intracellular 
staining (Fig. 5, A and B), mimicking decreased production   
of IFN- in naive mice (Fig. S1 B). The overall decrease of 
CD4+ cells (Fig. 2 E) further accentuates the decrease in abso-
lute numbers of IFN-–producing cells (not depicted). There-
fore, the question of whether diminished IFN- production is 
partially responsible for the protective effect of Il27ra deficiency 
merits consideration. Using IFN- neutralizing antibodies,   
others have previously reported a pathogenic role for IFN-  
in this model (Powrie et al., 1994). In our hands, IFN-/ 
 CD45Rbhi cells elicited less severe colitis, but also caused 
highly aggressive wasting disease requiring early termination 
of the experiment (Fig. S5, A–C). Consistent with findings 
obtained by others (Wang et al., 2006), IFN-/ CD45Rbhi 
cells had a diminished propensity to become Foxp3+ and ex-
panded more aggressively (Fig. S5, D and E). Thus, IFN- 
deficiency  phenocopies  IL-27Ra  deficiency  in  terms  of   
reduced colitis, but not in terms of the improved wasting   
disease, increased Treg conversion, or reduced expansion of ef-
fector cells. Therefore, a mere reduction in IFN- production 
cannot fully explain the Il27ra/ phenotype.
Conversely, and consistent with prior studies (Artis et al., 
2004; Batten et al., 2006; Stumhofer et al., 2006; Yang et al., 
2008), we observed mild elevations in TH17 (IL-17A and   
IL-22)  and  TH2  (IL-5  and  IL-13)  cytokines  produced  by 
Figure 5.  Reduced TH1 and enhanced TH17 polarization after 
transfer of Il27ra/ CD45Rbhi cells. (A) Representative IFN- and  
IL-22 intracellular cytokine staining of lamina propria isolates from CB17-
SCID mice injected with WT or Il27ra/ (KO) CD45Rbhi CD4+ T cells  
stimulated with PMA, ionomycin, and brefeldin A. Samples are gated on 
CD4+ cells. (B–E) Quantitative analysis of intracellular IFN- (B), IL-17A (C),  
IL-22 (D), and IL-13 (E) staining in splenocytes, mLNs, and colonic lamina  
propria lymphocytes from CB17-SCID mice transferred with WT or 
Il27ra/ CD45Rbhi cells. Data are representative of three individual  
experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.120 IL-27 promotes transfer colitis | Cox et al.
absence of IL-27Ra, which in turn de-represses Treg conver-
sion? Several of our data points favor the first of these two 
possibilities:  First,  IL-27  is  known  to  antagonize  TGF- 
driven Treg conversion in vitro (Fig. 3; Neufert et al., 2007; 
Huber et al., 2008), and thus conversion is expected to be 
de-restrained in Il27ra/ T cells in vivo. Second, we ob-
served an increase in absolute numbers, not just relative per-
centages, of Il27ra/ Foxp3+ T cells in our OVA-dependent 
tolerization model (Fig. 4). This difference persisted even in 
the context of established colitis (Fig. 4 F), and thus repre-
sents a cell intrinsic effect that is independent of the inflam-
mation status of the environment into which the cells are 
transferred. The OVA oral tolerance model is a much shorter 
term experiment than the 12-wk colitis study, and is there-
fore more amenable to mechanistic interpretation. And lastly, 
although a reduction in IFN- production could potentially 
explain the reduction in colitis, Treg conversion of IFN-/ 
T cells was not enhanced, and they still caused significant 
wasting disease. Therefore, reduced Treg conversion is not 
secondary to reduced production of IFN- in the absence of 
IL-27Ra.  In  summary,  these  observations  provide  strong 
suggestive evidence that the primary effect of IL-27 in this 
context is to restrain Treg conversion.
We attempted to therapeutically rescue mice with prees-
tablished transfer colitis by introducing Il27ra/ CD45Rbhi 
cells, but this experiment was not successful (Fig. S3). Al-
though a trend toward increased Foxp3 expression was still 
noticed 6 wk after transfer of the Il27ra/ CD45Rbhi cells 
into the inflammatory environment, and although the trans-
ferred cells clearly produced less IFN- (Fig. S3, F and G), 
we did not detect any changes in weight loss or colon length. 
This result suggests that although de-repression of Treg con-
version through loss of IL-27Ra at the onset of inflammation 
significantly affects the ultimate outcome, it is not robust 
enough to overcome preestablished inflammation.
Earlier studies by our group and others showed that IL-27 
can induce IL-10 production in T cells and lead to the devel-
opment of Foxp3, IFN-+IL-10+ Tr1 cells (Awasthi et al., 
2007; Fitzgerald et al., 2007; Stumhofer et al., 2007; Batten 
et al., 2008). Because Tr1 cells have potent immunoregula-
tory effects (Anderson et al., 2007; Jankovic et al., 2007; 
Trinchieri, 2007), it has been postulated that this is a mecha-
nism by which IL-27 exerts immune suppression in infec-
tious and autoimmune disease. These earlier observations are 
at odds with the proinflammatory role of IL-27 described 
here. However, in transfer colitis, IL-10 production by cells 
originating  from  the  Foxp3  CD45Rbhi  graft  is  minimal 
(Uhlig et al., 2006). We found no Il27ra-dependent differ-
ence in IL-10 production by transferred CD45Rbhi cells, and 
IL-10 production in general was minimal in this model (un-
published data). Thus, the Foxp3-suppressing effects of IL-27 
are not in contradiction with its Tr1-inducing effects; the di-
chotomy merely reflects the differences between the physio-
logical contexts in which IL-27 stimulation occurs and may 
explain why the essential function of IL-27 in the regulation 
of Treg differentiation has not been noted previously.
infiltration,  which  one  would  expect  as  a  consequence  of   
IL-17 overexpression (Fig. 6). Therefore, the minor relative 
changes in IL-17 and IL-22 production by Il27ra/ CD45Rbhi 
cells are unlikely to contribute significantly to disease protec-
tion, although IL-17 (Izcue et al., 2008; Leppkes et al., 2009; 
O’Connor et al., 2009) has been shown to either be neutral or 
exert protective effects in the context of this model, and IL-22 
is protective (Zenewicz et al., 2008).
DISCUSSION
We demonstrate conclusively that Il27ra/ CD45Rbhi T cells 
are less colitogenic than their WT counterparts in the murine 
transfer colitis model. Our analysis of the T cell graft after 12 wk 
of  incubation  in  lymphopenic  hosts  revealed  that  a  much 
greater proportion of IL27ra/ CD45Rbhi T cells assumed a 
Foxp3+ phenotype, whereas the remaining Foxp3 cells pro-
liferated less and produced much less of the TH1 cytokine 
IFN-. Although there were mild relative increases in Il27ra/ 
effector cells producing TH2 and TH17 cytokines, the lower 
abundance of Il27ra/ effector cells effectively neutralized this 
difference, which is consistent with the absence of an increase 
in neutrophil infiltration into the lamina propria. Therefore, 
the reduced colitis and weight loss in recipients of Il27ra/ 
CD45Rbhi T cells is a consequence of increased Treg conver-
sion, lower IFN- production, decreased effector cell prolifer-
ation, or a combination of these effects.
Together, the changes in T cell phenotype and abun-
dance form a chicken and egg conundrum: do effector cells 
proliferate less because there are more Foxp3+ cells present, 
or is there an increase in Foxp3+ cells because effector cells 
fail to proliferate and cause inflammation efficiently in the 
Figure 6.  Neutrophil content in the lamina propria of WT and 
Il27ra/ CD45Rbhi recipient mice. (A) Representative flow cytometry 
of colonic lamina propria isolates 12 wk after transfer of CD45Rbhi cells. 
Lamina propria leukocytes were surface stained with anti-Gr1 and anti-
CD11b. Quantification of percentage (B) and absolute number (C) of 
Gr1hiCD11b+ cells. Data are from one single experiment.JEM VOL. 208, January 17, 2011 
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colon and severe colitis, respectively. The scores of four anatomical regions 
were totaled for each mouse to yield a total histological score.
Flow cytometry. Single-cell suspensions were obtained from spleens and 
mLNs.  Lamina  propria  leukocytes  were  isolated  as  described  previously 
(Zheng et al., 2008). Cell counts were measured by ViaCount analysis on the 
Guava PCA-96 (Millipore). Anti-CD4 and anti-CD25 were used for surface 
staining of lymphocytes. For intracellular cytokine staining, single-cell sus-
pensions from spleens, mLNs, and lamina propria were restimulated for   
4 h in RPMI containing 10% FBS with 50 ng/ml of phorbol 12-myristate   
13-acetate and 500 ng/ml of ionomycin in the presence of 5 µg/ml of brefeldin 
A (Sigma-Aldrich). Cells were then fixed in 1% paraformaldehyde in PBS, 
permeabilized with 0.5% saponin in flow cytometry buffer (0.5% BSA in 
PBS), and stained intracellularly with PE-conjugated anti–IL-17, PECy7-
  conjugated anti–mouse IFN-, Alexa Fluor 647–conjugated anti–mouse   
IL-22 (Genentech), and PE-conjugated anti–mouse IL-13. Alternatively, Foxp3 
staining was performed according to manufacturer’s protocol (eBioscience).
In vitro conversion of DO11.10+ T cells. Lamina propria DCs were   
purified after collagenase treatment by sorting of CD11c+MHCII+ cells. 
DO11.10+CD4+ cells were MACS purified and incubated (5 × 104 cells/
well) with LPDCs (5 × 103 cells/well) in the presence of OVA323-339 (0.3 µM), 
TGF- (3 ng/ml), and IL-27 (20 ng/ml) as indicated. Cells were stimulated 
for 5 d in round-bottom 96-well plates, and intracellular Foxp3 was analyzed 
as described in the previous paragraph.
In vivo conversion of DO11.10+ T cells. CD4+ T lymphocytes were 
enriched (85% purity) from the spleens and mLNs of female Il27ra+/+ or 
Il27ra/ DO11.10+Rag2/ mice by negative MACS selection (Miltenyi 
Biotec). Female balb/c recipient mice (Taconic) were injected with 1.8 × 106 
cells I.V. on day 0. On day 1, mice were given 1.5% OVA (Grade V; Sigma-
Aldrich) dissolved in drinking water for 5 d, as previously described (Sun   
et al., 2007). OVA water was replaced every 48 h, and control mice received 
normal drinking water. On day 6, mice were sacrificed and spleens, mLNs, 
Peyer’s patches, and lamina propria lymphocytes were assessed for Foxp3 
expression. Cells were surface stained with PE-conjugated anti–KJ1-26 for 
the DO11.10 TCR, and then stained for intracellular IL-2, IFN-, or Foxp3. 
In some experiments, mice were injected with 3 × 105 WT CD45Rbhi cells 
to initiate colitis and, 4 wk later, were transferred with 2 × 106 CD4+DO11.10+ 
cells from WT or Il27ra/ mice. Mice were either given normal water or 
1.5% OVA for 5 d, as indicated.
Online supplemental material. Fig. S1 shows that naive Il27ra/ mice 
have unaltered levels of Foxp3+ Tregs and decreased levels of IFN-–producing 
CD4+ cells. Fig. S2 shows that Il27ra/ natural Treg have normal suppressive 
capacity. Fig. S3 shows that Il27ra/ CD45Rbhi cells fail to control previ-
ously established colitis. Fig. S4 shows cytokine expression during transfer   
colitis in recipients of WT or Il27ra/ cells, assessed by qPCR. Fig. S5   
details transfer colitis elicited by transfer of IFN-/ CD45Rbhi cells into 
rag2-deficient recipients. Onlen supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20100410/DC1.
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It is perhaps appropriate to point out that the majority   
of in vivo effects assigned to IL-27 have been inferred from 
the analysis of Il27ra/ mice, and only some have been con-
firmed by studies of Il27p28/ or Ebi3/ mice. This study 
is no different in that regard. To date, IL-27 is the only con-
firmed  ligand  for  IL-27Ra.  However,  IL-35  has  been   
described as an IL-27–related heterodimer with potent im-
munoregulatory effects (Collison et al., 2007, 2010). IL-35 
consists of IL-12p35 and Ebi3, and although its receptor has 
not been identified, IL-27Ra remains a candidate. Another 
recently described IL-27–related heterodimer consists of   
IL-27p28 and cytokine-like factor and appears to bind to   
IL-27Ra, but conclusive proof that IL-27Ra is required for 
signaling is currently not available (Crabé et al., 2009). Thus, 
it remains possible that IL-27Ra has ligands other than IL-27, 
which might further contribute to the apparent complexity 
and dichotomous nature of IL-27 biology in vivo.
In summary, we demonstrate that IL-27 exerts proinflam-
matory effects in the T cell transfer colitis model. Our exper-
iments demonstrate conclusively that IL-27 acts to suppress 
induced Treg development in vivo, and thus reveal a hitherto 
unrecognized proinflammatory mechanism. Collectively, our 
results suggest that targeting of IL-27 in situations where pa-
thology results from a breakdown in Treg-mediated tolerance 
may result in significant therapeutic benefit.
MATERIALS AND METHODS
Mice. All mice were maintained under pathogen-free conditions, and ex-
periments were approved by the Institutional Animal Care and Use Com-
mittee of Genentech, Inc. The Il27ra/ allele (Chen et al., 2000) was 
backcrossed onto the balb/c background for 12 generations. This strain was 
crossed further to the DO11.10+Rag2/ background (Taconic). CB17-
SCID  mice  were  purchased  from  Charles  River.  balb/c  and  Rag2/.
C57BL6 mice were obtained from Taconic.
Cytokines. Unless otherwise indicated, all cytokines were purchased 
from R&D Systems and all antibodies used in flow cytometry or culture 
experiments were purchased from BD. Anti-IL-22 (clone 3F11, isotype 
mouse  IgG2a;  Genentech)  was  directly  conjugated  to  Alexa  Fluor   
647 (Invitrogen).
Induction  of  colitis  with  naive  CD4+CD45Rbhi  T  cells.  Naive 
CD4+CD45Rbhi cells were isolated from the spleens of female Il27ra+/+ or 
Il27ra/ mice by FACS sorting. In brief, single-cell suspensions were de-
pleted of red blood cells by hypotonic lysis and CD4+ cells were purified by 
MACS-positive L3T4 selection (Miltenyi Biotec). After staining with Pacific 
blue–conjugated  anti-CD4,  PE-conjugated  anti-CD45Rb,  and  PECy5-
conjugated anti-CD44, CD4+CD44loCD45Rbhi naive T cells were purified 
(>98%) by cell sorting (FACSAria; BD). Female CB17-SCID mice were in-
jected with 3 × 105 CD45Rbhi cells or unsorted CD4+ cells i.v. Mice were 
monitored for weight loss and sacrificed by CO2 asphyxiation 11–12 wk   
after initiation of the experiment. Blood was obtained by retroorbital bleeds 
under isoflurane anesthesia at the indicated time points.
Assessment of intestinal inflammation. At the time of sacrifice, mouse 
colons were removed and flushed, and the length was measured from rectum 
to cecum. Tissues were immediately fixed in 10% buffered formalin, and   
4–5-µm paraffin-embedded sections were stained with hematoxylin and   
eosin. Colitis severity was scored in the proximal colon, medial colon, distal 
colon, and rectum on a scale of 0–5, with 0 and 5 representing a normal   122 IL-27 promotes transfer colitis | Cox et al.
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